echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Shanghai Jiujiu Biotechnology Co., Ltd. appoints Mr. Tian Feng as CEO

    Shanghai Jiujiu Biotechnology Co., Ltd. appoints Mr. Tian Feng as CEO

    • Last Update: 2022-03-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>



    "With Kinnate's lead BRAF inhibitor KIN-2787 entering Phase 1 clinical trials and the next-generation pan-FGFR inhibitor KIN-3248 recently receiving IND clearance from the US FDA, we expect that by building a longevity leadership team, The Greater China market is ready for potential new product development," said Dr.


    Mr.


    "I am very honored to join Jiujiu Bio and lead the company to solve the unmet clinical treatment needs of cancer patients in Greater China,


    The primary goal of Jiujiu Bio is to further promote the research and development of KIN-2787 in the Greater China market



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.